Oral Minoxidil May Better Slow Female Hair Loss

A new study shows oral minoxidil may more effectively slow hair loss progression in women than topical foam.

Updated on Oct. 30, 2026 in Women’s Health

A macro close-up of a single hair follicle under bright, sterile clinical lighting. — A retrospective study indicates that low-dose oral minoxidil may be more effective than topical foam in slowing the progression of female pattern hair loss. AI Illustration. Upload story photo >

Live Poll

Do you trust that medical treatments effectively prevent further hair loss?

A retrospective study comparing oral minoxidil to topical foam in 128 women shows differences in hair loss outcomes. Women using the low-dose oral medication experienced slower disease progression compared to those using the topical formulation.

Why it matters

Understanding the comparative efficacy of oral versus topical minoxidil helps clinicians and patients weigh treatment options for female pattern hair loss. This study highlights potential differences in how effectively each delivery method prevents hair loss from worsening.

In a retrospective cohort study of 128 women with female pattern hair loss, low-dose oral minoxidil led to a 2.8% disease progression rate compared to 21.1% in the topical 5% foam group. Researchers assessed changes using standardized scalp photographs scored by blinded, trained raters.

The players

Journal of the American Academy of Dermatology

A leading peer-reviewed medical journal that publishes clinical and investigative studies in the field of dermatology.

The details

The study measured treatment effectiveness using the Sinclair score, which tracks the severity of hair loss. Investigators utilized standardized scalp photographs evaluated by blinded raters and reviewed by a board-certified dermatologist to ensure accuracy. While oral minoxidil showed a lower rate of disease progression, stabilization rates remained similar between the two groups, with 34% for the oral group and 33% for the topical group.

October 29, 2026: The study was published in the Journal of the American Academy of Dermatology.

Health Landscape

The study adds to the evolving research landscape concerning the use of oral versus topical therapies for androgenetic alopecia. It reflects an ongoing effort to determine which delivery methods provide superior outcomes for long-term hair loss stabilization in women.

If you are currently managing female pattern hair loss, this study provides a meaningful point of comparison to discuss with your dermatologist. Ask your doctor about the potential risks and benefits of oral versus topical formulations to determine which approach best aligns with your health history.

The takeaway

While both delivery methods can help stabilize hair loss, low-dose oral minoxidil was linked to lower rates of disease progression than the topical foam in this study. Always consult your physician before changing your hair loss treatment plan or starting a new medication.